News & Events
The U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) launch the Artificial Kidney Prize Phase 2
$10.5 million is available for up to nine winners in two tracks.
UC Davis Professor Aijun Wang was awarded a $3 million grant by CIRM to develop a vascular device for hemodialysis patients treated for kidney failure.
Their device uses a unique molecule (LXW7) that promotes the binding of endothelial cells to synthetic grafts.
VenoStent Technology Receives Breakthrough Device Designation by FDA
The Center for Devices and Radiological Health (CDRH) at the Food and Drug Administration (FDA) has granted its novel technology, the SelfWrap® Bioabsorbable Perivascular Wrap, Breakthrough Device Designation (BDD).
Alio Inc., received FDA 510(k) clearance for its noninvasive remote monitoring system
Alio Inc. is developing a technology to monitor ESKD patients undergoing hemodialysis.
Public Comment Period Now Open for Human-Centered Design Toolkit for Kidney Failure
KHI is releasing a draft version of its Human-Centered Design Toolkit for Kidney Failure for public comment. The toolkit provides pre-clinical innovators and early-stage start-ups developing kidney replacement therapies with empathy tools to facilitate their interactions with people with kidney failure, enable market segmentation, and provide a framework for a customer requirements document.
Relavo, Inc. Awarded Grant from the National Science Foundation
KidneyX's Redesign Dialysis Phase 2 winner Relavo, Inc. received $1M from the National Science Foundation Small Business Innovation Research (SBIR) grant.
United States Ambassador Convenes Forum on Enhancing Kidney Health in the Pacific
The U.S. Ambassador Joseph Cella hosted Pacific health officials and clinicians for a dialogue on the prevention, diagnosis, and treatment of kidney disease. The conversation generated ideas and inspiration for new ways that the United States, Fiji, and other Pacific island countries can work together to overcome health challenges.
VenoStent has a new technology to improve outcomes for dialysis patients
Timothy Bouré and his co-founder Geoffrey Lucks were both near broke when they moved to Dallas to join the first accelerator they entered after forming VenoStent, a company that aims to improve outcomes for dialysis patients.
Student startup Relavo takes home $500,000 KidneyX prize
The award will support them as they work full-time on a solution for safer at-home dialysis—an issue they'll meet with greater urgency as the coronavirus pandemic makes in-person treatment riskier
